CollPlant Biotechnologies Ltd (CLGN)
4.31
-0.10
(-2.27%)
USD |
NASDAQ |
Nov 13, 16:00
CollPlant Biotechnologies Gross Profit Margin (Quarterly): -115.3% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -115.3% |
| March 31, 2024 | -456.1% |
| December 31, 2023 | -158.5% |
| September 30, 2023 | -546.5% |
| June 30, 2023 | 93.96% |
| March 31, 2023 | 24.94% |
| December 31, 2022 | -6.90% |
| September 30, 2022 | -142.2% |
| June 30, 2022 | 34.85% |
| March 31, 2022 | 53.03% |
| December 31, 2021 | -76.77% |
| September 30, 2021 | -1.43% |
| June 30, 2021 | 37.92% |
| March 31, 2021 | 93.89% |
| Date | Value |
|---|---|
| December 31, 2020 | 39.32% |
| September 30, 2020 | 65.26% |
| June 30, 2020 | 9.11% |
| March 31, 2020 | 22.00% |
| December 31, 2019 | 20.05% |
| September 30, 2019 | 5.01% |
| June 30, 2019 | 23.60% |
| March 31, 2019 | 29.29% |
| December 31, 2018 | 65.98% |
| September 30, 2018 | 66.07% |
| June 30, 2018 | 63.19% |
| March 31, 2018 | 88.89% |
| December 31, 2017 | 81.55% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-546.5%
Minimum
Sep 2023
93.96%
Maximum
Jun 2023
-53.13%
Average
20.05%
Median
Dec 2019
Gross Profit Margin (Quarterly) Benchmarks
| Compugen Ltd | 76.84% |
| Pluri Inc | -- |
| BioLine Rx Ltd | 83.37% |
| Can Fite Biofarma Ltd | -- |
| BiomX Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -61.54% |
| Return on Assets | -51.35% |
| Return on Invested Capital | -61.54% |
| Profit Margin (Quarterly) | -1.69K% |
| Operating Margin (Quarterly) | -1.77K% |
| Return on Net Operating Assets | -180.2% |